NeuroSense Therapeutics (NRSNW) Q4 2024 Earnings

Dec 18Confirmed
Jun 2021
Q2 2024
Q3 2024
Q4 2024
-0.35
-0.23
-0.12
0

Details

Expected EPS
-0.11
Actual EPS
-0.12
Surprise EPS
-0.01
Surprise Percent
-9.09%

Description

⁨NeuroSense Therapeutics⁩ (⁦NRSNW⁩) has reported earnings of ⁦-0.12⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts